Georgia Life Sciences Summit - Informed Horizons, LLC

Innovation for Global Health
David A. Dean, MD
Director, Heart Transplantation and
Mechanical Circulatory Support, Chief Heart
Failure Center of Excellence, Piedmont Heart
Institute
David Dean, MD is a heart transplant
Surgeon at Piedmont Hospital in Atlanta.
He received his Medical Degree at Robert
Wood Johnson Medical School, and did his
General Surgery training at Dartmouth Hitchcock Medical Center.
He was an NiH sponsored research scientist at Columbia University
where he focused on cardiac physiology and diastolic heart failure.
He completed his cardiac surgery and transplant training at The
University of North Carolina in Chapel Hill. Dr Dean has authored
over 50 peer reviewed manuscripts, presented at numerous national
meetings, and has been the Principal Investigator for many LVAD
clinical trials. He is a member of Alpha Omega Alpha at Dartmouth,
the Society of Thoracic Surgeons , the International Society for
Heart and Lung Transplant.
Abel De La Rosa, PhD
Former Senior VP, Business Development &
Scientific Affairs, Pharmasset, New Jersey
Dr. De La Rosa has been in the
biotechnology and pharmaceutical industry
for the past 17 years, and currently serves
on the Board of Directors of biotechnology
and not-for-profit companies. From 2002
until its acquisition by Gilead in early 2012,
Dr. De La Rosa was Senior Vice President of Business Development
& Scientific Affairs with Pharmasset, a company focused on the
discovery and development of antivirals. Prior to Pharmasset, Dr.
De La Rosa held both scientific and business positions at Visible
Genetics, where he was responsible for the development and
improvement of sequencing-based diagnostic tests for HIV, Hepatitis
C and Hepatitis B. Dr. De La Rosa also held scientific positions at
Innogenetics, Boston Biomedica, and Digene, developing molecular
diagnostic tests for infectious diseases. Prior to his career in
biotechnology, he earned a Fogarty Fellowship and an Intramural
Research Training Award Fellowship from the National Institutes of
Health, where he performed Post Doctoral cancer research in the
Laboratory of Biochemistry and the Laboratory of Pathology of the
National Cancer Institute. He is an inventor and author on several
U.S. patents and publications relating to molecular diagnostic
methods, techniques and therapeutics for infectious diseases and
cancer. Dr. De La Rosa holds a Bachelors Degree in Microbiology
from the University of California, San Diego, and a Masters Degree
and Ph.D. in Microbiology from Miami University.
2012 Georgia Life Sciences Summit
Frank DeStefano, MD, MPH
Director, Immunization Safety Office,
Division of Healthcare Quality Promotion,
National Center for Emerging and Zoonotic
Infectious Diseases, Centers for Disease
Control and Prevention, Georgia
Dr. DeStefano is the Director of the
Immunization Safety Office of the Centers
for Disease Control and Prevention (CDC).
He has had extensive epidemiologic research experience at CDC,
the National Institutes of Health, and at non-governmental
research organizations. His areas of research have included
immunizations, autism and other developmental disabilities,
reproductive health, veterans’ health, diabetes, cardiovascular
diseases, and other chronic diseases. Dr. DeStefano is an author
on over 150 publications in leading scientific and medical journals.
For the past 16 years Dr. DeStefano has had a focus on vaccine
safety. He is a graduate of Cornell University and the University of
Pittsburgh School of Medicine. He received training in public health
and preventive medicine in the Epidemic Intelligence Service and
preventive medicine residency at CDC. He obtained a Masters of
Public Health degree at Johns Hopkins University School of Hygiene
and Public Health.
Gary Del Vecchio
Executive Director US Pharmaceutical
Compliance, Bristol-Myers Squibb, New
Jersey
Mr. Del Vecchio has been with Bristol-
Myers Squibb for 25 years. His experience
includes roles within manufacturing
operations, quality control and assurance,
global manufacturing supply chain, systems
implementation, education and training, and compliance and ethics
program development and support. Gary has been a member of
the US Pharmaceuticals Compliance and Ethics department for
9 years and currently holds the position of Executive Director,
USP Compliance and Ethics. In this role he provides compliance
and ethics leadership to the Sales, Marketing, Medical, Access
and Global Commercialization organizations along with the
implementation and execution of the BMS Corporate Integrity
Agreement. His initial compliance role focused primarily on the
creation and implementation of the company’s comprehensive US
Compliance and Ethics education and training program. Gary is
currently serving as a Co-Chair of the Pharmaceutical Compliance
Forum, a coalition of senior compliance professionals and legal
counsel from approximately 65 of the largest research-based
pharmaceutical manufacturers. The PCF was founded in 1999
by compliance professionals from the pharmaceutical industry to
promote effective corporate compliance and ethics programs.
14
< Previous Page | Next Page >